Celltrion Poised for Profitability Leap on New Biosimilars

Biotech venture capital roundup: Osanni Bio leads with $190M Series B

A roundup of recent venture capital financings in the biotech sector, headlined by Osanni Bio's $190 million Series B round to fund drug can

Life Biosciences Begins First Human Trial of Cellular Rejuvenation Drug for Age-Related Vision Loss

Life Biosciences has dosed the first human patient with ER-100, a cellular rejuvenation therapy designed to reverse age-related sight loss b

RQ Bio secures $115M Series A for virus-targeting antibody pipeline

Protuoso Biosciences raises $9.5M for AI-designed multifunctional biologic drugs

Protuoso Biosciences, a California-based startup, has raised $9.5 million to advance its AI-designed multifunctional biologics platform. The

Evonik restructures R&D to accelerate biotech, circular economy, and energy transition innovations

Evonik Industries, a major German chemical producer, is restructuring its R&D operations to accelerate innovation in biotech, the circular e

How excessive FDA manufacturing requirements are bottlenecking cell and gene therapy companies

The article argues that excessive FDA manufacturing requirements are crippling cell and gene therapy companies, using Grace Therapeutics as